Columbia Research Enhanced Value ETF (NYSEARCA:REVS) Short Interest Update

Columbia Research Enhanced Value ETF (NYSEARCA:REVSGet Free Report) was the target of a large increase in short interest in the month of August. As of August 14th, there was short interest totaling 44,970 shares, an increase of 61.3% from the July 30th total of 27,888 shares. Approximately 0.4% of the company’s shares are short sold. Based on an average daily volume of 41,985 shares, the days-to-cover ratio is presently 1.1 days.

Hedge Funds Weigh In On Columbia Research Enhanced Value ETF

A number of institutional investors have recently bought and sold shares of REVS. Western Wealth Management LLC purchased a new stake in Columbia Research Enhanced Value ETF in the first quarter worth about $29,000. Steward Partners Investment Advisory LLC bought a new stake in Columbia Research Enhanced Value ETF during the 4th quarter valued at approximately $37,000. Cetera Investment Advisers purchased a new position in shares of Columbia Research Enhanced Value ETF during the 1st quarter worth approximately $300,000. Private Advisor Group LLC purchased a new position in shares of Columbia Research Enhanced Value ETF during the 3rd quarter worth approximately $448,000. Finally, Essex Financial Services Inc. raised its position in shares of Columbia Research Enhanced Value ETF by 108.5% in the 4th quarter. Essex Financial Services Inc. now owns 24,626 shares of the company’s stock worth $697,000 after acquiring an additional 12,815 shares in the last quarter.

Columbia Research Enhanced Value ETF Trading Down 0.6%

NYSEARCA REVS traded down $0.22 during trading on Monday, hitting $33.88. The company had a trading volume of 39,659 shares, compared to its average volume of 51,599. Columbia Research Enhanced Value ETF has a one year low of $27.24 and a one year high of $34.23. The company has a market cap of $338.80 million, a price-to-earnings ratio of 16.41 and a beta of 0.79. The company’s fifty day moving average is $33.05 and its 200-day moving average is $31.14.

Columbia Research Enhanced Value ETF Company Profile

(Get Free Report)

The Columbia Research Enhanced Value ETF (REVS) is an exchange-traded fund that mostly invests in large cap equity. The fund tracks an index of US stocks pulled from the Russell 1000 Value Index. REVS index uses multifactor selection and market cap weighting. REVS was launched on Sep 25, 2019 and is managed by Columbia.

See Also

Receive News & Ratings for Columbia Research Enhanced Value ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Columbia Research Enhanced Value ETF and related companies with MarketBeat.com's FREE daily email newsletter.